Notice of RetractionProfitability analysis of North China Pharmaceutical Co., Ltd

Notice of Retraction

After careful and considered review of the content of this paper by a duly constituted expert committee, this paper has been found to be in violation of IEEE´s Publication Principles.

We hereby retract the content of this paper. Reasonable effort should be made to remove all past references to this paper.

The presenting author of this paper has the option to appeal this decision by contacting TPII@ieee.org.

With the arrival of the financial crisis, the Chinese government has formulated and promulgated a series of policies and measures, to stimulate and support economic development. The competitive advantage of China´s large pharmaceutical companies may be more obvious, and is facing an excellent opportunity for bigger and stronger, which are conducive to sustainable development of China´s pharmaceutical industry. The Article choice eleven pharmaceutical companies which are the most competitival companies and include North China Pharmaceutical Co. Ltd., by analyzing the profitability of these pharmaceutical companies and then Pharmaceutical companies are compared, finally, we can analyze the the problems in profitability of North China Pharmaceutical Co. Ltd and put forward relevant proposals.